Member Info for Fruitsnveg

nice one

Don't disagree with you Andy, but I do hope the push back is swift and decisive.

Are you trading Ian?

I think in the longer-term no, initially we may see a small pullback but it will be across the market. Politcal events like these seem (historically at least) to not have much of a lasting affect on the markets, strangely. Blips, not much else. I think/hope any turned up aggression will be dealt with swiftly.

'pearls of wisdom'...lol.

https://www.theguardian.com/world/2021/apr/14/a-tsunami-of-cases-desperation-as-covid-second-wave-batters-india

" ...an increasing body of evidence, backed up by first-hand accounts from doctors on the frontline, also points to possible new variants in India which are proving to be drastically more infectious."

Not looking good.

Same here, no change in fundamentals, no sell.

Just topped up on HL @ 202. Love this share.

Tony, I suspect this is something the company are already working on (?), I would be very, very surprised if not - RM likes his precision medicine and has referred to it often enough in the past. It is the way forward. You have done some useful digging around, why not send them an email?

Yes, that caught my eye. This is going up.

It feels that way. My gut says we're going up.

Agree with you Hanoihank. Although I take the view that even without EUA (which is obv. very preferred), that will NOT exclude us from further negotiations in the future, it will not signify the 'end'. Thats' my opinion based on the fact that frankly, what are the alternatives for pharmas wanting to dominate the pulmonary space? If you are pharma wanting to improve your pipeine in that area in the next 5 - 10 years then you are going to want a slice of the virus agnostic treatment action. How many other companies have what we potentially have? If it moves quicker to the timelines you've given (which I agree with and hope for), then double quids in. Hoorah!

Hanoihank, I firmly believe that is the case btu I obv have no proof of this. But yes, Yes, I cannot see how the likes of Merck or AZ or Biogen or any number of other phramas in the pulmonary or IB space have not engaged somehow with Synairgen up to this point. I really can't. We will find out soon enough....

Thanks to all who took the time to crunch numbers on potential pricing. However, here's my thoughts - we are behind the curve on this. A takeover would take typically 2-3 months to negotiate (typically), so *assuming* that is where we end up, pricing, upon which negotiations will hinge, will have been firmed up in the past, not the future. On the other hand, if licencing is the route we end up taking, those interested partie(s) - pharma(s) - will have as much input as Synairgen in the pricing, and the research on that will have been deep and meaningful for all involved. All in all, it's an interesting topic but I believe not one that should take up too much of our brainpower at this point. There is not much that we can move the dial on this, and frankly, why would we want to?

And if that wasn't enough, both can cause blood clots.

Thanks Jakman59. See I remembered your name, even if I mis-typed it...Cheers.

No it was the same story yesterday. 10, 10, 10. Am watching .

Correct Meelie, RNS can take weeks from point of writing to issuing officially - I think it was Jkman(?) that posted a very good CEO overviewof what goes into RNSs. It's not a quick email they bang up in the morning and issue the next day, or even the next week.

Great toon Doc. Once in a lifetime (investment)? Here's hoping.

I think the market is well aware of the timelines we are working to Doc, and they will take advantage of that at every turn. Same as it ever was. The market loves a squeeze. And this too shall pass.